The family and friends of Robert A. (Bob) Stehlin, founder of the RASCALS Foundation, are hosting a Trivia Night, Saturday, September 6, 2014, in an effort to raise monies to assist his family with the financial burdens that ALS has placed on them over the past 5 years. Julie Tristan will be the Emcee for the evening.
Posts belonging to Category 501(c)(3) Non-Profit
CBS Sports Radio 920 and InsideSTL invite you to be their guest for their first Annual Charity Poker Classic presented by Miller Fortune at Lucas Park Grille on June 18th @ 6PM
Join us for food & drinks from Lucas Park and Miller Fortune, plus a fabulous night of poker and celebrities to benefit a [...]
The truth is that the ALS community needs all the help it can get. Not just during ALS Awareness Month in May, but 365 days a year.
Fact: There are people in whom ALS has stopped progressing and a small number of people in whom the symptoms of ALS reversed. Hopefully one day soon every patient’s symptoms will be reversed, and ALS itself erased from the planet. But we need your help.
Greater than 50% of all persons with living with ALS survive more than 3 years after diagnosis.
No single laboratory test or procedure can establish the diagnosis of Lou Gehrig’s disease. The patient’s medical history, physical examination, and neurological examination are usually sufficient to suggest the diagnosis of amyotrophic lateral sclerosis (ALS). However, it is still important to conduct a full investigation to exclude other conditions and to permit a detailed understanding of the areas involved by the disease.
Clearly the ALS community still has a long way to go to finding a cure, or even effective treatment options. And that’s also why fundraising is such an important part of what we do here at the RASCALS Foundation.
Physical therapy and special equipment can enhance patients’ independence and safety throughout the course of ALS.
Riluzole, the first treatment to alter the course of ALS, was approved by the FDA in late 1995. This antiglutamate drug was shown scientifically to prolong the life of persons with ALS by at least a few months.
Lou Gehrig’s disease eventually affects total body movement, as well as speech, swallowing and breathing. ALS ultimately results in a total body paralysis, inability to speak, inability to eat or drink by mouth, and inability to breathe unassisted. Finally there is simply an inability to breathe.